Fisher Scientific Completes Acquisition of Pharmaceutical Packaging Services Business from Covance Inc.
HAMPTON, N.H., Feb. 14 /PRNewswire/ --
Fisher Scientific International Inc. (NYSE: FSH), the world leader in serving science, announced today that it has completed the acquisition of the pharmaceutical packaging services business of Covance Inc. (NYSE: CVD) for $137.5 million, and has renamed it Fisher Clinical Services Inc.
(Photo: http://www.newscom.com/cgi-bin/prnh/20001109/NETH006 )
Fisher Clinical Services is a worldwide, leading provider of contract packaging services for clinical trials to major pharmaceutical and biotechnology companies, with cGMP (current Good Manufacturing Practices) manufacturing and packaging facilities in Allentown, Pa.; Basel, Switzerland; and Horsham, U.K.
Fisher Clinical Services enhances the company's current service offerings that include contract formulation and packaging of pharmaceutical, diagnostic and biotech products; custom synthesis for drug discovery; and manufacturing and sourcing of fine, organic and synthetic chemicals. Fisher also is the leading worldwide supplier of virtually all the products, supplies and equipment necessary to operate a research laboratory.
Fisher Scientific International Inc.
As the world leader in serving science, Fisher Scientific (www.fishersci.com) is the global source of laboratory supplies and equipment, e-commerce procurement technology and related services for research, healthcare, science education and occupational safety. Alchematrix (www.alchematrix.com), a business-to-business e-commerce subsidiary of Fisher Scientific, incorporates all of the capabilities and functionalities of fishersci.com, the world's largest and most comprehensive virtual marketplace for buying scientific supplies.
This announcement includes forward-looking statements. Fisher Scientific has based these forward-looking statements on their current expectations and projections about future events. Although Fisher Scientific believes that its assumptions made in connection with the forward-looking statements are reasonable, no assurances can be given that their assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions. Fisher Scientific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur.
Note to Editors: Today's news release, along with other news about Fisher Scientific is available on the Internet at www.fisherscientific.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 14, 2001|
|Previous Article:||BEZEQ ISRAELI TELECOMMUNICATION CORPORATION LTD.|
|Next Article:||SPICE UP YOUR LOVE LIFE WITH CALIFORNIA ALMONDS THIS VALENTINE'S DAY!|